BD welcomes new insulin injection and infusion recommendations

BD has welcomed the publication of new insulin delivery recommendations for healthcare professionals caring for insulin-using patients, including people with diabetes.

Appearing in the medical journal Mayo Clinic Proceedings, the recommendations indicate that patients should be using the shortest available needles, as many of those currently in use are longer and thicker than recommended, while the use of pen needles and syringes to should be limited to one-time administration.

It was also noted that one-third of those taking insulin have nodules or bumps in the fat tissue at their injection sites, creating a need for better rotation of the points of injection.

These recommendations were based on findings from the largest-ever international survey of more than 13,200 insulin-injecting patients from 42 countries, which was carried out as part of the BD-sponsored Forum for Injection Technique and Therapy Expert Recommendations (FITTER) international workshop.

Two of the papers published in Mayo Clinic Proceedings addressed the key findings from the FITTER survey, while a third presented the new insulin delivery recommendations.

Dr Kenneth Strauss, co-author and medical director of BD in Europe, said: "If these recommendations become routine practice, we should soon see the improved outcomes that come from optimised insulin delivery."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.